Please login to the form below

Not currently logged in
Email:
Password:

Ergomed appoints CEO of PrimeVigilance

Dr Jan Petracek to drive pharmacoviglance business

Jan_Petracek_ErgomedErgomed has appointed Dr Jan Petracek the new CEO of its pharmacoviglance business PrimeVigilance.

Dr Petracek was previously CEO of European PharmInvent Services, which Ergomed acquired in 2016 and subsequently integrated into PrimeVigilance, and prior to that he served at the likes of MediWound and Vertext Pharmaceuticals.

Dr Miroslav Reljanovic, CEO of Ergomed, said: “We are fortunate to have in the wings a replacement CEO of the calibre of Dr Jan Petracek.

“As founder of PharmInvent and former regulator at EMA, his unique combination of entrepreneurship and specialist pharmacoviglance expertise will serve to drive forward our pharmacoviglance businesses.”

Petracek will succeed Neil Clark who will become CEO of Destiny Pharma and will remain on Ergomed’s board of PrimeVigilance as a non-executive director and consultant during a transition period.

26th April 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics